We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+17.1%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$14.1B
AUM Growth
+$1.4B
(+11%)
Cap. Flow
-$4.28B
Cap. Flow
% of AUM
-30.25%
Top 10 Holdings %
Top 10 Hldgs %
20.4%
Holding
803
New
108
Increased
91
Reduced
295
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BSX.PRA
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
|
+$61M |
| 2 |
RTX Corp
RTX
|
+$38.2M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$15.5M |
| 4 |
Delta Air Lines
DAL
|
+$14.5M |
| 5 |
SWT
Stanley Black & Decker, Inc.
SWT
|
+$13.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$578M |
| 2 |
AGN
Allergan plc
AGN
|
+$67M |
| 3 |
BDXA
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
|
+$51.1M |
| 4 |
Alibaba
BABA
|
+$46.8M |
| 5 |
lululemon athletica
LULU
|
+$42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.91% |
| 2 | Healthcare | 8.15% |
| 3 | Consumer Discretionary | 7.49% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
S&P Global
SPGI
$130B
| $15.4M | 0.11% |
46,877
-2,995
| -6% | -$901K |
|
152
Danaher
DHR
$138B
| $15.2M | 0.11% |
96,779
-141,552
| -59% | -$20.3M |
|
153
Sysco
SYY
$40.2B
| $15.1M | 0.11% |
276,457
+156,182
| +130% | +$8.21M |
|
|
CNP.PRB
154
DELISTED
CenterPoint Energy, Inc. Depositary Shares Each Representing a 1/20th Interest in a Share of 7.00% S
CNP.PRB
| $14.9M | 0.11% |
420,000
| – | – |
|
|
AVTR.PRA
155
DELISTED
Avantor, Inc. Series A Mandatory Convertible Preferred Stock
AVTR.PRA
| $14.9M | 0.11% |
259,500
+59,500
| +30% | +$3.33M |
|
156
iShares MSCI United Kingdom ETF
EWU
$4.05B
| $14.8M | 0.1% |
574,500
| – | – |
|
157
CVS Health
CVS
$137B
| $14.7M | 0.1% |
226,672
-12,607
| -5% | -$794K |
|
158
Wynn Resorts
WYNN
$10.3B
| $14.7M | 0.1% |
197,533
+147,533
| +295% | +$11.8M |
|
159
Capital One
COF
$127B
| $14.6M | 0.1% |
232,984
-87,105
| -27% | -$5.43M |
|
160
3M
MMM
$91.9B
| $14.1M | 0.1% |
108,182
-6,922
| -6% | -$872K |
|
|
161
CALL
Alibaba
BABA
$276B
| $14.1M | 0.1% |
+65,400
| New | +$13.6M |
|
162
CALL
Meta Platforms (Facebook)
META
$1.51T
| $14.1M | 0.1% |
+62,000
| New | +$12.9M |
|
163
CALL
Apple
AAPL
$4.95T
| $13.7M | 0.1% |
+150,000
| New | +$11.6M |
|
164
CALL
Lam Research
LRCX
$365B
| $13.6M | 0.1% |
+420,000
| New | +$11.5M |
|
165
Intuit
INTU
$83.1B
| $13.5M | 0.1% |
45,528
-2,913
| -6% | -$799K |
|
166
Automatic Data Processing
ADP
$102B
| $13.5M | 0.1% |
90,425
-5,786
| -6% | -$829K |
|
167
Texas Instruments
TXN
$255B
| $13.4M | 0.1% |
105,893
-6,776
| -6% | -$790K |
|
168
Becton Dickinson
BDX
$43.8B
| $13.4M | 0.09% |
57,433
-3,674
| -6% | -$885K |
|
|
ALXN
169
DELISTED
Alexion Pharmaceuticals
ALXN
| $13.3M | 0.09% |
118,740
-289,115
| -71% | -$30.7M |
|
170
Chipotle Mexican Grill
CMG
$42.6B
| $13.3M | 0.09% |
+629,950
| New | +$11.7M |
|
171
Air Products & Chemicals
APD
$65.2B
| $13.2M | 0.09% |
54,511
-61,860
| -53% | -$14.1M |
|
172
DTE Energy
DTE
$30.6B
| $13.1M | 0.09% |
143,495
| – | – |
|
173
IBM
IBM
$204B
| $13.1M | 0.09% |
113,699
-7,275
| -6% | -$845K |
|
174
Duke Energy
DUK
$100B
| $13M | 0.09% |
162,542
-10,282
| -6% | -$869K |
|
175
Edwards Lifesciences
EW
$47.8B
| $12.8M | 0.09% |
184,510
-6,221
| -3% | -$442K |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Calamos Advisors held 803 positions worth $14.1B, up 11% from $12.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Calamos Advisors withdrew a net $4.28B in Q2 2020, closing 98 positions and reducing 295 holdings. Its most notable exit was Allergan plc, an estimated $67M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Calamos Advisors opened a new position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A worth $59.7M.
- Calamos Advisors's largest Q2 2020 buy was Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A: 569,916 shares worth $59.7M.
- Calamos Advisors added most to RTX Corp in Q2 2020, an estimated $38.2M increase.
- Calamos Advisors's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $578M.
- Calamos Advisors fully exited Allergan plc in Q2 2020, selling an estimated $67M.
- Calamos Advisors's ten largest holdings make up 20% of its $14.1B portfolio in Q2 2020.
- Calamos Advisors opened 108 new positions and closed 98 in Q2 2020.
- Calamos Advisors's portfolio value rose 11% quarter-over-quarter to $14.1B.
Based on Calamos Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.